STERISCAF HSA Trademark

Trademark Overview

On Monday, January 23, 2017, a trademark application was filed for STERISCAF HSA with the United States Patent and Trademark Office. The USPTO has given the STERISCAF HSA trademark a serial number of 87310093. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, October 4, 2024. This trademark is owned by Tissue Transplant Technology, Ltd.. The STERISCAF HSA trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
steriscaf hsa

General Information

Serial Number87310093
Word MarkSTERISCAF HSA
Filing DateMonday, January 23, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, October 4, 2024
Registration Number5716128
Registration DateTuesday, April 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2018

Trademark Statements

Goods and ServicesHuman allograft tissue
NOT AVAILABLE"HSA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 27, 2017
Primary Code005
First Use Anywhere DateFriday, September 1, 2017
First Use In Commerce DateFriday, September 1, 2017

Trademark Owner History

Party NameTissue Transplant Technology, Ltd.
Party Type30 - Original Registrant
Legal Entity Type02 - Partnership
AddressSan Antonio, TX 78240
Party NameTissue Transplant Technology, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type02 - Partnership
AddressSan Antonio, TX 78240
Party NameTissue Transplant Technology, Ltd.
Party Type10 - Original Applicant
Legal Entity Type02 - Partnership
AddressSan Antonio, TX 78240

Trademark Events

Event DateEvent Description
Friday, January 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 26, 2017NEW APPLICATION ENTERED
Wednesday, April 19, 2017ASSIGNED TO EXAMINER
Thursday, April 20, 2017NON-FINAL ACTION WRITTEN
Thursday, April 20, 2017NON-FINAL ACTION E-MAILED
Thursday, April 20, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 25, 2017ASSIGNED TO LIE
Wednesday, November 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 1, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 23, 2017NON-FINAL ACTION WRITTEN
Thursday, November 23, 2017NON-FINAL ACTION E-MAILED
Thursday, November 23, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 17, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 14, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, April 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 2, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 22, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 22, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 14, 2019USE AMENDMENT FILED
Thursday, February 7, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 8, 2019STATEMENT OF USE PROCESSING COMPLETE
Saturday, February 23, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 26, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 2, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, April 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 3, 2024TEAS SECTION 8 & 15 RECEIVED
Friday, October 4, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, October 4, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, October 4, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

steriscaf tissue allograft human